Biohaven

📍 New Haven, United States🗓 Founded 2022👥 392 employees💰 Last funded Mar 2022
Biotechnology Research🌐 biohaven.com
Website LinkedIn
Biohaven is a uniquely different pharmaceutical company. We are an agile and resilient team of highly skilled professionals who eagerly challenge the status quo to advance novel, life-changing therapies. People are at the center of all we do. The unmet needs of patients inspire us to follow scientific innovation wherever it leads and motivates our resolve for overcoming the obstacles that stand in the way of medical progress. It is all part of the patient-first culture we proudly call the “Biohaven Way.” If you’d like to join us, please visit our Careers page: https://www.biohaven.com/careers/ For Investor news and financial information about Biohaven (NYSE: BHVN): https://ir.biohaven.com/ View our Pipeline: https://www.biohaven.com/pipeline/
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Italy
1
United States
1
Frequently asked questions
Who invested in Biohaven?
Biohaven has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Biohaven last raise funding?
The most recent investment in Biohaven recorded on gritt.io was in March 2022.
When was Biohaven founded?
Biohaven was founded in 2022.
What industry is Biohaven in?
Biohaven operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Biohaven based?
Biohaven is headquartered in New Haven, United States.